Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Intra-articular injections provide rapid relief of joint inflammation and are often used to treat acute attacks of osteoarthritis, especially when joint effusions are present.
Global Intra-Articular Injection market is projected to reach US$ 16290 million in 2029, increasing from US$ 7900 million in 2022, with the CAGR of 10.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Intra-Articular Injection market research.
Key manufacturers engaged in the Intra-Articular Injection industry include Zimmer Biomet, Sanofi, Fidia, Farmaceutici, J & J, Bioventis, Anika Therapeutics, Ferring and Freda, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Intra-Articular Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Intra-Articular Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Intra-Articular Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Segment by Type
Segment by Application
Consumption by Region
The Intra-Articular Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index
1 Intra-Articular Injection Market Overview
1.1 Product Overview and Scope of Intra-Articular Injection
1.2 Intra-Articular Injection Segment by Type
1.2.1 Global Intra-Articular Injection Market Value Comparison by Type (2023-2029)
1.2.2 Hyaluronic Acid
1.2.3 Glucocorticoids
1.2.4 Medical Chitosan
1.2.5 Growth Factors and Platelet Rich Plasma
1.3 Intra-Articular Injection Segment by Application
1.3.1 Global Intra-Articular Injection Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Intra-Articular Injection Market Size Estimates and Forecasts
1.4.1 Global Intra-Articular Injection Revenue 2018-2029
1.4.2 Global Intra-Articular Injection Sales 2018-2029
1.4.3 Global Intra-Articular Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Intra-Articular Injection Market Competition by Manufacturers
2.1 Global Intra-Articular Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Intra-Articular Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Intra-Articular Injection Average Price by Manufacturers (2018-2023)
2.4 Global Intra-Articular Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Intra-Articular Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intra-Articular Injection, Product Type & Application
2.7 Intra-Articular Injection Market Competitive Situation and Trends
2.7.1 Intra-Articular Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intra-Articular Injection Players Market Share by Revenue
2.7.3 Global Intra-Articular Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intra-Articular Injection Retrospective Market Scenario by Region
3.1 Global Intra-Articular Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Intra-Articular Injection Global Intra-Articular Injection Sales by Region: 2018-2029
3.2.1 Global Intra-Articular Injection Sales by Region: 2018-2023
3.2.2 Global Intra-Articular Injection Sales by Region: 2024-2029
3.3 Global Intra-Articular Injection Global Intra-Articular Injection Revenue by Region: 2018-2029
3.3.1 Global Intra-Articular Injection Revenue by Region: 2018-2023
3.3.2 Global Intra-Articular Injection Revenue by Region: 2024-2029
3.4 North America Intra-Articular Injection Market Facts & Figures by Country
3.4.1 North America Intra-Articular Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Intra-Articular Injection Sales by Country (2018-2029)
3.4.3 North America Intra-Articular Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intra-Articular Injection Market Facts & Figures by Country
3.5.1 Europe Intra-Articular Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Intra-Articular Injection Sales by Country (2018-2029)
3.5.3 Europe Intra-Articular Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intra-Articular Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Intra-Articular Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Intra-Articular Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Intra-Articular Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intra-Articular Injection Market Facts & Figures by Country
3.7.1 Latin America Intra-Articular Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Intra-Articular Injection Sales by Country (2018-2029)
3.7.3 Latin America Intra-Articular Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Intra-Articular Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Intra-Articular Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Intra-Articular Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Intra-Articular Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intra-Articular Injection Sales by Type (2018-2029)
4.1.1 Global Intra-Articular Injection Sales by Type (2018-2023)
4.1.2 Global Intra-Articular Injection Sales by Type (2024-2029)
4.1.3 Global Intra-Articular Injection Sales Market Share by Type (2018-2029)
4.2 Global Intra-Articular Injection Revenue by Type (2018-2029)
4.2.1 Global Intra-Articular Injection Revenue by Type (2018-2023)
4.2.2 Global Intra-Articular Injection Revenue by Type (2024-2029)
4.2.3 Global Intra-Articular Injection Revenue Market Share by Type (2018-2029)
4.3 Global Intra-Articular Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Intra-Articular Injection Sales by Application (2018-2029)
5.1.1 Global Intra-Articular Injection Sales by Application (2018-2023)
5.1.2 Global Intra-Articular Injection Sales by Application (2024-2029)
5.1.3 Global Intra-Articular Injection Sales Market Share by Application (2018-2029)
5.2 Global Intra-Articular Injection Revenue by Application (2018-2029)
5.2.1 Global Intra-Articular Injection Revenue by Application (2018-2023)
5.2.2 Global Intra-Articular Injection Revenue by Application (2024-2029)
5.2.3 Global Intra-Articular Injection Revenue Market Share by Application (2018-2029)
5.3 Global Intra-Articular Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Zimmer Biomet
6.1.1 Zimmer Biomet Corporation Information
6.1.2 Zimmer Biomet Description and Business Overview
6.1.3 Zimmer Biomet Intra-Articular Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Zimmer Biomet Intra-Articular Injection Product Portfolio
6.1.5 Zimmer Biomet Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Corporation Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Intra-Articular Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Sanofi Intra-Articular Injection Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Fidia
6.3.1 Fidia Corporation Information
6.3.2 Fidia Description and Business Overview
6.3.3 Fidia Intra-Articular Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Fidia Intra-Articular Injection Product Portfolio
6.3.5 Fidia Recent Developments/Updates
6.4 Farmaceutici
6.4.1 Farmaceutici Corporation Information
6.4.2 Farmaceutici Description and Business Overview
6.4.3 Farmaceutici Intra-Articular Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Farmaceutici Intra-Articular Injection Product Portfolio
6.4.5 Farmaceutici Recent Developments/Updates
6.5 J & J
6.5.1 J & J Corporation Information
6.5.2 J & J Description and Business Overview
6.5.3 J & J Intra-Articular Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 J & J Intra-Articular Injection Product Portfolio
6.5.5 J & J Recent Developments/Updates
6.6 Bioventis
6.6.1 Bioventis Corporation Information
6.6.2 Bioventis Description and Business Overview
6.6.3 Bioventis Intra-Articular Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Bioventis Intra-Articular Injection Product Portfolio
6.6.5 Bioventis Recent Developments/Updates
6.7 Anika Therapeutics
6.6.1 Anika Therapeutics Corporation Information
6.6.2 Anika Therapeutics Description and Business Overview
6.6.3 Anika Therapeutics Intra-Articular Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Anika Therapeutics Intra-Articular Injection Product Portfolio
6.7.5 Anika Therapeutics Recent Developments/Updates
6.8 Ferring
6.8.1 Ferring Corporation Information
6.8.2 Ferring Description and Business Overview
6.8.3 Ferring Intra-Articular Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Ferring Intra-Articular Injection Product Portfolio
6.8.5 Ferring Recent Developments/Updates
6.9 Freda
6.9.1 Freda Corporation Information
6.9.2 Freda Description and Business Overview
6.9.3 Freda Intra-Articular Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Freda Intra-Articular Injection Product Portfolio
6.9.5 Freda Recent Developments/Updates
6.10 Meiji Seika Pharma
6.10.1 Meiji Seika Pharma Corporation Information
6.10.2 Meiji Seika Pharma Description and Business Overview
6.10.3 Meiji Seika Pharma Intra-Articular Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Meiji Seika Pharma Intra-Articular Injection Product Portfolio
6.10.5 Meiji Seika Pharma Recent Developments/Updates
6.11 Genzyme Corporation
6.11.1 Genzyme Corporation Corporation Information
6.11.2 Genzyme Corporation Intra-Articular Injection Description and Business Overview
6.11.3 Genzyme Corporation Intra-Articular Injection Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Genzyme Corporation Intra-Articular Injection Product Portfolio
6.11.5 Genzyme Corporation Recent Developments/Updates
6.12 LG Chem
6.12.1 LG Chem Corporation Information
6.12.2 LG Chem Intra-Articular Injection Description and Business Overview
6.12.3 LG Chem Intra-Articular Injection Sales, Revenue and Gross Margin (2018-2023)
6.12.4 LG Chem Intra-Articular Injection Product Portfolio
6.12.5 LG Chem Recent Developments/Updates
6.13 Seikagaku Corporation
6.13.1 Seikagaku Corporation Corporation Information
6.13.2 Seikagaku Corporation Intra-Articular Injection Description and Business Overview
6.13.3 Seikagaku Corporation Intra-Articular Injection Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Seikagaku Corporation Intra-Articular Injection Product Portfolio
6.13.5 Seikagaku Corporation Recent Developments/Updates
6.14 Bloomage Bio
6.14.1 Bloomage Bio Corporation Information
6.14.2 Bloomage Bio Intra-Articular Injection Description and Business Overview
6.14.3 Bloomage Bio Intra-Articular Injection Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Bloomage Bio Intra-Articular Injection Product Portfolio
6.14.5 Bloomage Bio Recent Developments/Updates
6.15 Haohai Biotechnology
6.15.1 Haohai Biotechnology Corporation Information
6.15.2 Haohai Biotechnology Intra-Articular Injection Description and Business Overview
6.15.3 Haohai Biotechnology Intra-Articular Injection Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Haohai Biotechnology Intra-Articular Injection Product Portfolio
6.15.5 Haohai Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intra-Articular Injection Industry Chain Analysis
7.2 Intra-Articular Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intra-Articular Injection Production Mode & Process
7.4 Intra-Articular Injection Sales and Marketing
7.4.1 Intra-Articular Injection Sales Channels
7.4.2 Intra-Articular Injection Distributors
7.5 Intra-Articular Injection Customers
8 Intra-Articular Injection Market Dynamics
8.1 Intra-Articular Injection Industry Trends
8.2 Intra-Articular Injection Market Drivers
8.3 Intra-Articular Injection Market Challenges
8.4 Intra-Articular Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research